Featured
MANTRA Surat textile research IIT Kanpur, the blunt times
MANTRA Invited to IIT Kanpur Textile Policy Dialogue
How AI is Revolutionizing Cybersecurity in 2026: Threats, Defenses, and the Future
Realme P4s 5G Review: Flagship-Grade AMOLED Display Stands Out
August 27, 2026
The Blunt Times The Blunt Times
  • National
  • City Events
  • Business Vibes
  • Education
  • Entertainment
  • Regional
    • Bharuch
    • Dang
    • Navsari
    • Surat
    • Valsad
    • Hindi
    • Gujarati
  • Health
  • Crime corner
  • Sports
  • Spotlight
Search the Site
Popular Searches:
Chatgpt Nasa Halloween
Recent Posts
PuREPower
PuREPower Launches India’s 1st All-In-One C&I BESS Product
August 27, 2026
When Real Estate Meets Broadway: Inside Prateek Group’s Most Theatrical Evening yet
When Real Estate Meets Broadway: Inside Prateek Group’s Most Theatrical Evening yet
August 27, 2026
Chandra Grahan 2026: Year’s Last Lunar Eclipse on August 28 Check Timing and Visibility
August 27, 2026
The Blunt Times The Blunt Times
  • National
  • City Events
  • Business Vibes
  • Education
  • Entertainment
  • Regional
    • Bharuch
    • Dang
    • Navsari
    • Surat
    • Valsad
    • Hindi
    • Gujarati
  • Health
  • Crime corner
  • Sports
  • Spotlight
Follow us
Gujarat pharma companies clinical trials, the blunt times
Home/National/Gujarat Pharma Firms Exploiting Unemployed in Clinical Trials
National

Gujarat Pharma Firms Exploiting Unemployed in Clinical Trials

Ahmedabad | Gujarat –— Pharma companies in Gujarat are under fire for allegedly exploiting unemployed citizens by drawing them into repeated clinical drug trials, often without proper...

Times News Network
September 8, 2025 3 Min Read

Ahmedabad | Gujarat –— Pharma companies in Gujarat are under fire for allegedly exploiting unemployed citizens by drawing them into repeated clinical drug trials, often without proper safeguards. While such trials are legal if cleared by regulators, activists argue that many being conducted in Ahmedabad and surrounding regions cross the line into unethical—and possibly unauthorised—practices.

For vulnerable participants, the lure of quick cash has come at devastating costs. Afzal Ajmeri, a former mechanic from Sarkhej, described how years of trial participation left him physically and mentally broken.

“For the last five to six years, I’ve been earning only through clinical trials. They kept me in their research centres for days, gave me tablets, and drew blood samples at fixed hours. For each such package, I received between ₹10,000 and ₹15,000,” Ajmeri told reporters.

‘I ruined myself for money’

Under Indian rules, a participant is allowed to enroll only once or twice a year, with strict intervals between studies. But Ajmeri admitted to enrolling far more frequently. “For the sake of money, I would go four to five times a year,” he said.

The consequences have been grim. Once a breadwinner for his family, Ajmeri now struggles with basic tasks and lives in near isolation. “My life is ruined. I cannot even support my family anymore,” he said, his voice heavy with regret.

Middlemen targeting the poor

Clinical research centres dotting the Sarkhej–Gandhinagar highway and Sanand industrial belt are reportedly recruiting unemployed youth and women through middlemen. The pitch is simple: “Eat these pills, earn money.”

Activists say most participants are poor, uneducated, and unaware of the risks. Consent forms are either not properly explained or bypassed altogether.

Activists call it exploitation

Social activist Ahmedhusen Kansara condemned the practices as deliberate exploitation. “In Sarkhej and Fatehwadi, not only unemployed men but also women are drawn into these trials. Afzal’s own sister fell ill after one such drug test. Companies deliberately keep poor and illiterate people in the dark about side effects,” he said.

Kansara added that his group is preparing both awareness campaigns and legal action. “We will demand compensation for victims whose health has been damaged. No life should be destroyed for the profit of pharma companies,” he declared.

Weak oversight and global shift

India’s Clinical Trials Registry mandates that all drug studies be registered and conducted under strict ethical guidelines. But experts say enforcement is weak, creating fertile ground for abuse.

With tighter monitoring in Europe and the US, pharma firms are increasingly shifting trials to developing countries like India, where regulations are loosely applied. Ahmedabad recently saw unauthorised trials exposed at VS Hospital, highlighting systemic gaps.

Economic desperation fuels the cycle

High unemployment and rising inflation in Gujarat worsen the problem, pushing people to risk their health for short-term income. Agents exploit this desperation, dangling cash rewards while concealing dangers.

While participants earn between ₹10,000 and ₹15,000 per trial, the hidden costs can be catastrophic. Repeated exposure to untested drugs may lead to chronic illness, deformities, paralysis, or even death.

A local advocate warned: “These trials are marketed as easy money. But the long-term price is people losing their health, their livelihoods, even their lives. It’s exploitation disguised as opportunity.”

Demands for accountability

The growing outcry has placed Gujarat’s booming pharmaceutical industry under scrutiny. Civil society groups are demanding stricter inspections, criminal liability for unauthorised trials, and compensation for victims.

Tags:

Ahmedabad pharma trial controversyclinical trial side effects GujaratGujaratGujarat pharma companiesSarkhej drug trialsunemployed exploited by pharmaunethical clinical trials India

Share Article

IIM
Previous Post

IIM Lucknow Invites Applications for Batch 3 of Executive Programme in Leadership & Change Management

Best Hotels in Port Blair: Mansha Hotels Redefining Luxury and Culinary Excellence -TBT
Next Post

A New Benchmark for Hospitality in Port Blair-Mansha Hotels Redefining Luxury and Culinary Excellence

Picked
Indian Air Force Prepares C-130 Aircraft for Nepal Flood Relief Mission
MANTRA Surat textile research IIT Kanpur, the blunt times
MANTRA Invited to IIT Kanpur Textile Policy Dialogue
How AI is Revolutionizing Cybersecurity in 2026: Threats, Defenses, and the Future
Realme P4s 5G Review: Flagship-Grade AMOLED Display Stands Out
iPhone 18 Pro Cost Increase: Price Could Rise by $100
Apple Mac mini M6 Chip Brings 2nm Performance and Major AI Upgrades
Popular Posts
iPhone 18 Pro Cost Increase: Price Could Rise by $100
By Santhosh Kumar
Apple Mac mini M6 Chip Brings 2nm Performance and Major AI Upgrades
By Santhosh Kumar
Anthropic Signs $45 Billion Cloud Deal With Nscale for AI Compute
By Santhosh Kumar
Indian AI Company Orders 9,000 Nvidia GPUs for Massive Hyderabad AI Factory
By Santhosh Kumar
Essential Online Developer Tools for Everyday Web Development
By Santhosh Kumar
DNS Filtering Lists: How They Work and How They Help Protect Against Fraud
By Santhosh Kumar

Read Next

PuREPower
Business
PuREPower Launches India’s 1st All-In-One C&I BESS Product
August 27, 2026
2 Min Read
National
Indian Air Force Prepares C-130 Aircraft for Nepal Flood Relief Mission
August 27, 2026
2 Min Read
MANTRA Surat textile research IIT Kanpur, the blunt times
National
MANTRA Invited to IIT Kanpur Textile Policy Dialogue
August 27, 2026
2 Min Read
Mukesh Mahalinga
National
Odisha Health Minister Dr. Mukesh Mahalinga visits Sri Sathya Sai Heart Hospital
August 26, 2026
1 Min Read
The Blunt Times

The Blunt Times is a 24-hour news portal from Surat and south Gujarat. It was launched by senior journalist Melvyn Thomas, who has over 21 years of experience working with the top news organizations such as The Indian Express, The Times of India, and The Economic Times.

Popular
Indian Air Force Prepares C-130 Aircraft for Nepal Flood Relief Mission
August 27, 2026
MANTRA Invited to IIT Kanpur Textile Policy Dialogue
August 27, 2026
How AI is Revolutionizing Cybersecurity in 2026: Threats, Defenses, and the Future
August 27, 2026
Realme P4s 5G Review: Flagship-Grade AMOLED Display Stands Out
August 27, 2026
Categories
City Events
National
Business Vibes
Lifestyle
Business
Education
Spotlight
Regional
Entertainment
Health
Press Release
Sports

© 2026 All Rights Reserved, The Blunt Times

  • Terms of Service
  • Privacy Policy